|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4571 USD | -1.42% |
|
-0.37% | -68.69% |
RedHill Biopharma Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was USD 5.4 million compared to USD 31.45 million a year ago. Net income was USD 51 million compared to net loss of USD 32.24 million a year ago.
Basic earnings per share from continuing operations was USD 16 compared to basic loss per share from continuing operations of USD 24 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -68.69% | 14.78M | |
| -1.12% | 89.37B | |
| +2.76% | 40.65B | |
| -12.32% | 32.81B | |
| +52.41% | 25B | |
| -17.39% | 15.29B | |
| -42.45% | 11.61B | |
| -10.48% | 11.49B | |
| +6.14% | 8.98B | |
| -7.72% | 8.23B |
REDHILL BIOPHARMA LTD. 